{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:17:16Z","timestamp":1784639836565,"version":"3.55.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["17CSA33590101"],"award-info":[{"award-number":["17CSA33590101"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18POST33960526"],"award-info":[{"award-number":["18POST33960526"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18POST34080160"],"award-info":[{"award-number":["18POST34080160"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18CDA34110411"],"award-info":[{"award-number":["18CDA34110411"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["13POST14480004"],"award-info":[{"award-number":["13POST14480004"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007491","name":"Donald E. and Delia B. Baxter Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007421","name":"Li Ka Shing Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000888","name":"W. M. Keck Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011098","name":"SU | Stanford Bio-X","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011098","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stanford University Vice Provost for Undergraduate Education Major Grant"},{"name":"Stanford University Translational Research and Applied Medicine Pilot Grant, Stanford University School of Medicine Dean\u2019s Postdoctoral Fellowship"},{"DOI":"10.13039\/100012496","name":"Swiss National Science Foundation | nccr \u2013 on the move","doi-asserted-by":"publisher","award":["P2SKP2_164954"],"award-info":[{"award-number":["P2SKP2_164954"]}],"id":[{"id":"10.13039\/100012496","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Regen Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Duchenne muscular dystrophy (DMD) is a progressive genetic myopathy that leads to heart failure from dilated cardiomyopathy by early adulthood. Recent evidence suggests that tamoxifen, a selective estrogen receptor modulator widely used to treat breast cancer, ameliorates DMD cardiomyopathy. However, the mechanism of action of 4-hydroxytamoxifen, the active metabolite of tamoxifen, on cardiomyocyte function remains unclear. To examine the effects of chronic 4-hydroxytamoxifen treatment, we used state-of-the-art human-induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) and a bioengineered platform to model DMD. We assessed the beating rate and beating velocity of iPSC-CMs in monolayers and as single cells on micropatterns that promote a physiological cardiomyocyte morphology. We found that 4-hydroxytamoxifen treatment of DMD iPSC-CMs decreased beating rate, increased beating velocity, and ameliorated calcium-handling deficits, leading to prolonged viability. Our study highlights the utility of a bioengineered iPSC-CM platform for drug testing and underscores the potential of repurposing tamoxifen as a therapy for DMD cardiomyopathy.<\/jats:p>","DOI":"10.1038\/s41536-022-00214-x","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T11:12:04Z","timestamp":1647601924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Tamoxifen treatment ameliorates contractile dysfunction of Duchenne muscular dystrophy stem cell-derived cardiomyocytes on bioengineered substrates"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6062-2296","authenticated-orcid":false,"given":"Foster","family":"Birnbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3010-0275","authenticated-orcid":false,"given":"Asuka","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9177-1174","authenticated-orcid":false,"given":"Gaspard","family":"Pardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9441-4033","authenticated-orcid":false,"given":"Alex C. Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6503-5480","authenticated-orcid":false,"given":"Helen M.","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"214_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1001\/jamaneurol.2015.3537","volume":"73","author":"MA Gatheridge","year":"2016","unstructured":"Gatheridge, M. A. et al. Identifying non\u2013Duchenne muscular dystrophy\u2013positive and false negative results in prior Duchenne muscular dystrophy newborn screening programs: a review. JAMA Neurol. 73, 111 (2016).","journal-title":"JAMA Neurol."},{"key":"214_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1083\/jcb.201212142","volume":"201","author":"F Rahimov","year":"2013","unstructured":"Rahimov, F. & Kunkel, L. M. Cellular and molecular mechanisms underlying muscular dystrophy. J. Cell Biol. 201, 499\u2013510 (2013).","journal-title":"J. Cell Biol."},{"key":"214_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.22758","volume":"36","author":"CL Bladen","year":"2015","unstructured":"Bladen, C. L. et al. The TREAT-NMD DMD global database: analysis of more than 7,000 Duchenne muscular dystrophy mutations. Hum. Mutat. 36, 395\u2013402 (2015).","journal-title":"Hum. Mutat."},{"key":"214_CR4","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/cphy.c140048","volume":"5","author":"QQ Gao","year":"2015","unstructured":"Gao, Q. Q. & McNally, E. M. The dystrophin complex: structure, function, and implications for therapy. Compr. Physiol. 5, 1223\u20131239 (2015).","journal-title":"Compr. Physiol."},{"key":"214_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2006.09.016","volume":"36","author":"N Deconinck","year":"2007","unstructured":"Deconinck, N. & Dan, B. Pathophysiology of Duchenne muscular dystrophy: current hypotheses. Pediatr. Neurol. 36, 1\u20137 (2007).","journal-title":"Pediatr. Neurol."},{"key":"214_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mus.22097","volume":"44","author":"CF Spurney","year":"2011","unstructured":"Spurney, C. F. Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions. Muscle Nerve 44, 8\u201319 (2011).","journal-title":"Muscle Nerve"},{"key":"214_CR7","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1136\/heartjnl-2017-311269","volume":"103","author":"D D\u2019Amario","year":"2017","unstructured":"D\u2019Amario, D. et al. A current approach to heart failure in Duchenne muscular dystrophy. Heart 103, 1770\u20131779 (2017).","journal-title":"Heart"},{"key":"214_CR8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/ncb2790","volume":"15","author":"F Mourkioti","year":"2013","unstructured":"Mourkioti, F. et al. Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy. Nat. Cell Biol. 15, 895\u2013904 (2013).","journal-title":"Nat. Cell Biol."},{"key":"214_CR9","doi-asserted-by":"publisher","first-page":"13120","DOI":"10.1073\/pnas.1615340113","volume":"113","author":"ACY Chang","year":"2016","unstructured":"Chang, A. C. Y. et al. Telomere shortening and metabolic compromise underlie dystrophic cardiomyopathy. Proc. Natl Acad. Sci. USA 113, 13120\u201313125 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"214_CR10","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","volume":"67","author":"F Kamdar","year":"2016","unstructured":"Kamdar, F. & Garry, D. J. Dystrophin-deficient cardiomyopathy. J. Am. Coll. Cardiol. 67, 2533\u20132546 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"214_CR11","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.3390\/jcm9103186","volume":"9","author":"R Adorisio","year":"2020","unstructured":"Adorisio, R. et al. Duchenne dilated cardiomyopathy: cardiac management from prevention to advanced cardiovascular therapies. J. Clin. Med. 9, 3186 (2020).","journal-title":"J. Clin. Med."},{"key":"214_CR12","doi-asserted-by":"publisher","first-page":"ra56","DOI":"10.1126\/scisignal.2002829","volume":"5","author":"RJ Khairallah","year":"2012","unstructured":"Khairallah, R. J. et al. Microtubules underlie dysfunction in Duchenne muscular dystrophy. Sci. Signal. 5, ra56 (2012).","journal-title":"Sci. Signal."},{"key":"214_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant, D. J. et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 17, 347\u2013361 (2018).","journal-title":"Lancet Neurol."},{"key":"214_CR14","doi-asserted-by":"publisher","first-page":"e006340","DOI":"10.1161\/JAHA.117.006340","volume":"6","author":"D Cheeran","year":"2021","unstructured":"Cheeran, D. et al. Predictors of death in adults with Duchenne muscular dystrophy-associated cardiomyopathy. J. Am. Heart Assoc. 6, e006340 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"214_CR15","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1161\/CIRCULATIONAHA.114.015151","volume":"131","author":"EM McNally","year":"2015","unstructured":"McNally, E. M. et al. Contemporary cardiac issues in Duchenne muscular dystrophy. Circulation 131, 1590\u20131598 (2015).","journal-title":"Circulation"},{"key":"214_CR16","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/mus.24163","volume":"50","author":"C Spurney","year":"2014","unstructured":"Spurney, C. et al. Cooperative international neuromuscular research group Duchenne natural history study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy. Muscle Nerve 50, 250\u2013256 (2014).","journal-title":"Muscle Nerve"},{"key":"214_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2533\/chimia.2018.238","volume":"72","author":"E Gayi","year":"2018","unstructured":"Gayi, E. et al. Repurposing the selective oestrogen receptor modulator tamoxifen for the treatment of Duchenne muscular dystrophy. Chimia 72, 238\u2013240 (2018).","journal-title":"Chimia"},{"key":"214_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ajpath.2012.10.018","volume":"182","author":"OM Dorchies","year":"2013","unstructured":"Dorchies, O. M. et al. The anticancer drug Tamoxifen counteracts the pathology in a mouse model of Duchenne muscular dystrophy. Am. J. Pathol. 182, 485\u2013504 (2013).","journal-title":"Am. J. Pathol."},{"key":"214_CR19","doi-asserted-by":"publisher","unstructured":"Arnott, J., Martinkovich, S., Planey, S. L. & Shah, D. Selective estrogen receptor modulators: tissue specificity and clinical utility. Clin. Interv. Aging 1437, https:\/\/doi.org\/10.2147\/CIA.S66690 (2014).","DOI":"10.2147\/CIA.S66690"},{"key":"214_CR20","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1096\/fj.05-5148com","volume":"20","author":"S Mahmoodzadeh","year":"2006","unstructured":"Mahmoodzadeh, S. et al. Estrogen receptor alpha up\u2010regulation and redistribution in human heart failure. FASEB J. 20, 926\u2013934 (2006).","journal-title":"FASEB J."},{"key":"214_CR21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/GCO.0b013e3283488a21","volume":"23","author":"AN Kallen","year":"2011","unstructured":"Kallen, A. N. & Pal, L. Cardiovascular disease and ovarian function. Curr. Opin. Obstet. Gynecol. 23, 258\u2013267 (2011).","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"214_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/MNH.0b013e3283431921","volume":"20","author":"X-P Yang","year":"2011","unstructured":"Yang, X.-P. & Reckelhoff, J. F. Estrogen, hormonal replacement therapy and cardiovascular disease. Curr. Opin. Nephrol. Hypertens. 20, 133\u2013138 (2011).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"214_CR23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/0960-0760(91)90292-D","volume":"40","author":"RW Koot","year":"1991","unstructured":"Koot, R. W., Amelink, G. J., Blankenstein, M. A. & B\u00e4r, P. R. Tamoxifen and oestrogen both protect the rat muscle against physiological damage. J. Steroid Biochem. Mol. Biol. 40, 689\u2013IN10 (1991).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"214_CR24","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/0006-2952(94)90073-6","volume":"47","author":"Jos\u00e9BA Cust\u00f3dio","year":"1994","unstructured":"Cust\u00f3dio, Jos\u00e9B. A., Dinis, T. C. P., Almeida, L. M. & Madeira, V. M. C. Tamoxifen and hydroxytamoxifen as intramembraneous inhibitors of lipid peroxidation. Evidence for peroxyl radical scavenging activity. Biochem. Pharmacol. 47, 1989\u20131998 (1994).","journal-title":"Biochem. Pharmacol."},{"key":"214_CR25","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/sj.bjp.0703924","volume":"132","author":"ML Dodds","year":"2001","unstructured":"Dodds, M. L., Kargacin, M. E. & Kargacin, G. J. Effects of anti-oestrogens and \u03b2-estradiol on calcium uptake by cardiac sarcoplasmic reticulum. Br. J. Pharmacol. 132, 1374\u20131382 (2001).","journal-title":"Br. J. Pharmacol."},{"key":"214_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.pharep.2014.02.004","volume":"66","author":"BM Patel","year":"2014","unstructured":"Patel, B. M. & Desai, V. J. Beneficial role of tamoxifen in experimentally induced cardiac hypertrophy. Pharmacol. Rep. 66, 264\u2013272 (2014).","journal-title":"Pharmacol. Rep."},{"key":"214_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3740-6","volume":"20","author":"S Nagy","year":"2019","unstructured":"Nagy, S. et al. Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial. Trials 20, 637 (2019).","journal-title":"Trials"},{"key":"214_CR28","doi-asserted-by":"publisher","first-page":"9276","DOI":"10.1073\/pnas.1714538115","volume":"115","author":"ACY Chang","year":"2018","unstructured":"Chang, A. C. Y. et al. Telomere shortening is a hallmark of genetic cardiomyopathies. Proc. Natl Acad. Sci. USA 115, 9276\u20139281 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"214_CR29","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.stem.2019.02.015","volume":"24","author":"JZ Zhang","year":"2019","unstructured":"Zhang, J. Z. et al. A human iPSC double-reporter system enables purification of cardiac lineage subpopulations with distinct function and drug response profiles. Cell Stem Cell 24, 802\u2013811.e5 (2019).","journal-title":"Cell Stem Cell"},{"key":"214_CR30","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1093\/eurheartj\/ehz326","volume":"40","author":"H Wu","year":"2019","unstructured":"Wu, H. et al. Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients. Eur. Heart J. 40, 3685\u20133695 (2019).","journal-title":"Eur. Heart J."},{"key":"214_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.stemcr.2021.04.018","volume":"16","author":"ACY Chang","year":"2021","unstructured":"Chang, A. C. Y. et al. Increased tissue stiffness triggers contractile dysfunction and telomere shortening in dystrophic cardiomyocytes. Stem Cell Rep. 16, 1\u201313 (2021).","journal-title":"Stem Cell Rep."},{"key":"214_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1161\/CIRCRESAHA.114.300558","volume":"114","author":"X Yang","year":"2014","unstructured":"Yang, X., Pabon, L. & Murry, C. E. Engineering adolescence: maturation of human pluripotent stem cell\u2013derived cardiomyocytes. Circ. Res. 114, 511\u2013523 (2014).","journal-title":"Circ. Res."},{"key":"214_CR33","doi-asserted-by":"crossref","unstructured":"Kn\u00f6ll, R., Buyandelger, B. & Lab, M. The sarcomeric Z-disc and Z-discopathies. J. Biomed. Biotechnol. 2011, 1\u201312 (2011).","DOI":"10.1155\/2011\/569628"},{"key":"214_CR34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.yjmcc.2011.06.012","volume":"51","author":"WE Louch","year":"2011","unstructured":"Louch, W. E. Methods in cardiomyocyte isolation, culture, and gene transfer. J. Mol. Cell. Cardiol. 51, 288\u2013298 (2011).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"214_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13590-y","volume":"7","author":"AM da Rocha","year":"2017","unstructured":"da Rocha, A. M. et al. hiPSC-CM monolayer maturation state determines drug responsiveness in high throughput pro-arrhythmia screen. Sci. Rep. 7, 13834 (2017).","journal-title":"Sci. Rep."},{"key":"214_CR36","doi-asserted-by":"publisher","first-page":"120973","DOI":"10.1016\/j.biomaterials.2021.120973","volume":"275","author":"CM Madl","year":"2021","unstructured":"Madl, C. M., Flaig, I. A., Holbrook, C. A., Wang, Y. X. & Blau, H. M. Biophysical matrix cues from the regenerating niche direct muscle stem cell fate in engineered microenvironments. Biomaterials 275, 120973 (2021).","journal-title":"Biomaterials"},{"key":"214_CR37","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1124\/pr.116.013003","volume":"72","author":"DT Paik","year":"2020","unstructured":"Paik, D. T., Chandy, M. & Wu, J. C. Patient and disease-specific induced pluripotent stem cells for discovery of personalized cardiovascular drugs and therapeutics. Pharmacol. Rev. 72, 320\u2013342 (2020).","journal-title":"Pharmacol. Rev."},{"key":"214_CR38","doi-asserted-by":"publisher","first-page":"12705","DOI":"10.1073\/pnas.1508073112","volume":"112","author":"AJS Ribeiro","year":"2015","unstructured":"Ribeiro, A. J. S. et al. Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness. Proc. Natl Acad. Sci. USA 112, 12705\u201312710 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"214_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pbiomolbio.2018.12.001","volume":"144","author":"A Schroer","year":"2019","unstructured":"Schroer, A., Pardon, G., Castillo, E., Blair, C. & Pruitt, B. Engineering hiPSC cardiomyocyte in vitro model systems for functional and structural assessment. Prog. Biophys. Mol. Biol. 144, 3\u201315 (2019).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"214_CR40","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1089\/ten.tec.2014.0283","volume":"21","author":"N Huebsch","year":"2015","unstructured":"Huebsch, N. et al. Automated video-based analysis of contractility and calcium flux in human-induced pluripotent stem cell-derived cardiomyocytes cultured over different spatial scales. Tissue Eng. Part C. Methods 21, 467\u2013479 (2015).","journal-title":"Tissue Eng. Part C. Methods"},{"key":"214_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/srep08883","volume":"5","author":"A Mathur","year":"2015","unstructured":"Mathur, A. et al. Human iPSC-based cardiac microphysiological system for drug screening applications. Sci. Rep. 5, 8883 (2015).","journal-title":"Sci. Rep."},{"key":"214_CR42","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1161\/CIRCRESAHA.119.316100","volume":"126","author":"T Sakamoto","year":"2020","unstructured":"Sakamoto, T. et al. A critical role for estrogen-related receptor signaling in cardiac maturation. Circ. Res. 126, 1685\u20131702 (2020).","journal-title":"Circ. Res."},{"key":"214_CR43","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.scr.2013.12.004","volume":"12","author":"X Guan","year":"2014","unstructured":"Guan, X. et al. Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery. Stem Cell Res. 12, 467\u2013480 (2014).","journal-title":"Stem Cell Res."},{"key":"214_CR44","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/cvr\/cvz109","volume":"116","author":"JM Pioner","year":"2020","unstructured":"Pioner, J. M. et al. Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human-induced pluripotent stem cells. Cardiovasc. Res. 116, 368\u2013382 (2020).","journal-title":"Cardiovasc. Res."},{"key":"214_CR45","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.scr.2010.10.002","volume":"6","author":"E Dick","year":"2011","unstructured":"Dick, E. et al. Two new protocols to enhance the production and isolation of human induced pluripotent stem cell lines. Stem Cell Res. 6, 158\u2013167 (2011).","journal-title":"Stem Cell Res."},{"key":"214_CR46","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1089\/scd.2013.0135","volume":"22","author":"E Dick","year":"2013","unstructured":"Dick, E. et al. Exon skipping and gene transfer restore dystrophin expression in human induced pluripotent stem cells-cardiomyocytes harboring DMD mutations. Stem Cells Dev. 22, 2714\u20132724 (2013).","journal-title":"Stem Cells Dev."},{"key":"214_CR47","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1161\/CIRCGENETICS.109.867242","volume":"2","author":"RW Kaspar","year":"2009","unstructured":"Kaspar, R. W. et al. Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in Becker muscular dystrophy. Circ. Cardiovasc. Genet. 2, 544\u2013551 (2009).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"214_CR48","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/hmg\/4.9.1475","volume":"4","author":"RC Austin","year":"1995","unstructured":"Austin, R. C., Howard, P. L., D\u2019Souza, V. N., Klamut, H. J. & Ray, P. N. Cloning and characterization of alternatively spliced isoforms of Dp71. Hum. Mol. Genet. 4, 1475\u20131483 (1995).","journal-title":"Hum. Mol. Genet."},{"key":"214_CR49","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3389\/fbioe.2020.00535","volume":"8","author":"S Jelinkova","year":"2020","unstructured":"Jelinkova, S. et al. DMD pluripotent stem cell derived cardiac cells recapitulate in vitro human cardiac pathophysiology. Front. Bioeng. Biotechnol. 8, 535 (2020).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"214_CR50","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1242\/jcs.02814","volume":"119","author":"R Barresi","year":"2006","unstructured":"Barresi, R. & Campbell, K. P. Dystroglycan: from biosynthesis to pathogenesis of human disease. J. Cell Sci. 119, 199\u2013207 (2006).","journal-title":"J. Cell Sci."},{"key":"214_CR51","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.jacc.2019.12.066","volume":"75","author":"F Kamdar","year":"2020","unstructured":"Kamdar, F. et al. Stem cell-derived cardiomyocytes and beta-adrenergic receptor blockade in Duchenne muscular dystrophy cardiomyopathy. J. Am. Coll. Cardiol. 75, 1159\u20131174 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"214_CR52","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.yjmcc.2006.05.022","volume":"41","author":"AB Ropero","year":"2006","unstructured":"Ropero, A. B. et al. Heart estrogen receptor alpha: distinct membrane and nuclear distribution patterns and regulation by estrogen. J. Mol. Cell. Cardiol. 41, 496\u2013510 (2006).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"214_CR53","doi-asserted-by":"publisher","first-page":"075","DOI":"10.1159\/000204096","volume":"23","author":"E Lizotte","year":"2009","unstructured":"Lizotte, E., Grandy, S. A., Tremblay, A., Allen, B. G. & Fiset, C. Expression, distribution and regulation of sex steroid hormone receptors in mouse heart. Cell. Physiol. Biochem. 23, 075\u2013086 (2009).","journal-title":"Cell. Physiol. Biochem."},{"key":"214_CR54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/rmb2.12006","volume":"16","author":"P Ya\u015far","year":"2016","unstructured":"Ya\u015far, P., Ayaz, G., User, S. D., G\u00fcp\u00fcr, G. & Muyan, M. Molecular mechanism of estrogen\u2013estrogen receptor signaling. Reprod. Med. Biol. 16, 4\u201320 (2016).","journal-title":"Reprod. Med. Biol."},{"key":"214_CR55","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/adt.2011.0396","volume":"9","author":"MKB Jonsson","year":"2011","unstructured":"Jonsson, M. K. B., Wang, Q.-D. & Becker, B. Impedance-based detection of beating rhythm and proarrhythmic effects of compounds on stem cell-derived cardiomyocytes. ASSAY Drug Dev. Technol. 9, 589\u2013599 (2011).","journal-title":"ASSAY Drug Dev. Technol."},{"key":"214_CR56","doi-asserted-by":"crossref","unstructured":"Lemoine, M. D. et al. Human induced pluripotent stem cell\u2013derived engineered heart tissue as a sensitive test system for QT prolongation and arrhythmic triggers. Circ. Arrhythm. Electrophysiol. 11, e006035 (2018).","DOI":"10.1161\/CIRCEP.117.006035"},{"key":"214_CR57","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1161\/CIRCULATIONAHA.112.000570","volume":"128","author":"EG Navarrete","year":"2013","unstructured":"Navarrete, E. G. et al. Screening drug-induced arrhythmia using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays. Circulation 128, S3\u2013S13 (2013).","journal-title":"Circulation"},{"key":"214_CR58","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.hrthm.2010.09.017","volume":"7","author":"JN Weiss","year":"2010","unstructured":"Weiss, J. N., Garfinkel, A., Karagueuzian, H. S., Chen, P.-S. & Qu, Z. Early afterdepolarizations and cardiac arrhythmias. Heart Rhythm 7, 1891\u20131899 (2010).","journal-title":"Heart Rhythm"},{"key":"214_CR59","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1126\/science.1202768","volume":"333","author":"BL Prosser","year":"2011","unstructured":"Prosser, B. L., Ward, C. W. & Lederer, W. J. X-ROS signaling: rapid mechano-chemo transduction in heart. Science 333, 1440\u20131445 (2011).","journal-title":"Science"},{"key":"214_CR60","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/mus.21763","volume":"42","author":"B Bostick","year":"2010","unstructured":"Bostick, B., Yue, Y. & Duan, D. Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy. Muscle Nerve 42, 600\u2013603 (2010).","journal-title":"Muscle Nerve"},{"key":"214_CR61","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cell.2010.11.039","volume":"143","author":"A Sacco","year":"2010","unstructured":"Sacco, A. et al. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx\/mTR mice. Cell 143, 1059\u20131071 (2010).","journal-title":"Cell"},{"key":"214_CR62","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd1031","volume":"2","author":"VC Jordan","year":"2003","unstructured":"Jordan, V. C. Tamoxifen: a most unlikely pioneering medicine. Nat. Rev. Drug Discov. 2, 205\u2013213 (2003).","journal-title":"Nat. Rev. Drug Discov."},{"key":"214_CR63","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molmed.2012.12.007","volume":"19","author":"J Cui","year":"2013","unstructured":"Cui, J., Shen, Y. & Li, R. Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol. Med. 19, 197\u2013209 (2013).","journal-title":"Trends Mol. Med."},{"key":"214_CR64","first-page":"4677","volume":"84","author":"MM Grumbach","year":"1999","unstructured":"Grumbach, M. M. & Auchus, R. J. Estrogen: consequences and implications of human mutations in synthesis and action. J. Clin. Endocrinol. Metab. 84, 4677\u20134694 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"214_CR65","doi-asserted-by":"publisher","first-page":"592912","DOI":"10.3389\/fphar.2020.592912","volume":"11","author":"J Yao","year":"2020","unstructured":"Yao, J., Deng, K., Huang, J., Zeng, R. & Zuo, J. Progress in the understanding of the mechanism of tamoxifen resistance in breast cancer. Front. Pharmacol. 11, 592912 (2020).","journal-title":"Front. Pharmacol."},{"key":"214_CR66","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/39645","volume":"389","author":"AM Brzozowski","year":"1997","unstructured":"Brzozowski, A. M. et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753\u2013758 (1997).","journal-title":"Nature"},{"key":"214_CR67","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","volume":"95","author":"AK Shiau","year":"1998","unstructured":"Shiau, A. K. et al. The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95, 927\u2013937 (1998).","journal-title":"Cell"},{"key":"214_CR68","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mce.2009.03.009","volume":"308","author":"MR Meyer","year":"2009","unstructured":"Meyer, M. R., Haas, E., Prossnitz, E. R. & Barton, M. Non-genomic regulation of vascular cell function and growth by estrogen. Mol. Cell. Endocrinol. 308, 9\u201316 (2009).","journal-title":"Mol. Cell. Endocrinol."},{"key":"214_CR69","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1210\/mend.16.1.0758","volume":"16","author":"EJ Filardo","year":"2002","unstructured":"Filardo, E. J., Quinn, J. A., Frackelton, A. R. & Bland, K. I. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol. Endocrinol. 16, 70\u201384 (2002).","journal-title":"Mol. Endocrinol."},{"key":"214_CR70","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1476-5381.1992.tb14403.x","volume":"106","author":"C Jiang","year":"1992","unstructured":"Jiang, C. et al. Effect of 17\u03b2\u2010oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea\u2010pig isolated cardiac myocytes. Br. J. Pharmacol. 106, 739\u2013745 (1992).","journal-title":"Br. J. Pharmacol."},{"key":"214_CR71","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/jnci\/dji342","volume":"97","author":"B Nordenskj\u00f6ld","year":"2005","unstructured":"Nordenskj\u00f6ld, B. et al. Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy: results from a randomized trial. JNCI J. Natl Cancer Inst. 97, 1609\u20131610 (2005).","journal-title":"JNCI J. Natl Cancer Inst."},{"key":"214_CR72","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1200\/JCO.1995.13.12.2900","volume":"13","author":"H Gylling","year":"1995","unstructured":"Gylling, H. et al. Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer. J. Clin. Oncol. 13, 2900\u20132905 (1995).","journal-title":"J. Clin. Oncol."},{"key":"214_CR73","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/S0026-0495(98)90078-6","volume":"47","author":"AL Holleran","year":"1998","unstructured":"Holleran, A. L., Lindenthal, B., Aldaghlas, T. A. & Kelleher, J. K. Effect of tamoxifen on cholesterol synthesis in HepG2 cells and cultured rat hepatocytes. Metabolism 47, 1504\u20131513 (1998).","journal-title":"Metabolism"},{"key":"214_CR74","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1124\/jpet.103.060426","volume":"308","author":"Pde Medina","year":"2004","unstructured":"Medina, P. de. et al. Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells. J. Pharmacol. Exp. Ther. 308, 1165\u20131173 (2004).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"214_CR75","doi-asserted-by":"publisher","first-page":"860","DOI":"10.7326\/0003-4819-115-11-860","volume":"115","author":"RR Love","year":"1991","unstructured":"Love, R. R. et al. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women. Ann. Intern. Med. 115, 860 (1991).","journal-title":"Ann. Intern. Med."},{"key":"214_CR76","doi-asserted-by":"publisher","first-page":"E1848","DOI":"10.1073\/pnas.1200250109","volume":"109","author":"X Lian","year":"2012","unstructured":"Lian, X. et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl Acad. Sci. USA 109, E1848\u2013E1857 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"214_CR77","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nmeth.2999","volume":"11","author":"PW Burridge","year":"2014","unstructured":"Burridge, P. W. et al. Chemically defined generation of human cardiomyocytes. Nat. Methods 11, 855\u2013860 (2014).","journal-title":"Nat. Methods"},{"key":"214_CR78","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","volume":"12","author":"S Tohyama","year":"2013","unstructured":"Tohyama, S. et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 12, 127\u2013137 (2013).","journal-title":"Cell Stem Cell"}],"container-title":["npj Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41536-022-00214-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-022-00214-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-022-00214-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T14:09:09Z","timestamp":1669298949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41536-022-00214-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["214"],"URL":"https:\/\/doi.org\/10.1038\/s41536-022-00214-x","relation":{},"ISSN":["2057-3995"],"issn-type":[{"value":"2057-3995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]},"assertion":[{"value":"4 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}